David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZNGA
276
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $58.1M | 0.09% |
15,376,260
+3,593,217
| +30% | +$13.2M |
|
277
Fortune Brands Innovations
FBIN
$5.32B
| $57.5M | 0.09% |
1,001,440
+8,053
| +0.8% | +$446K |
|
|
ESRX
278
DELISTED
Express Scripts Holding Company
ESRX
| $57.2M | 0.09% |
903,230
+210,115
| +30% | +$13.1M |
|
279
Boeing
BA
$169B
| $57.1M | 0.09% |
+224,596
| New | +$52.4M |
|
280
Equity Lifestyle Properties
ELS
$12.7B
| $56.9M | 0.09% |
1,338,120
-44,986
| -3% | -$1.96M |
|
281
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
| $56.9M | 0.09% |
1,481,997
+268,000
| +22% | +$10.4M |
|
282
Visteon
VC
$2.83B
| $56.7M | 0.09% |
457,804
+12,902
| +3% | +$1.46M |
|
283
Intel
INTC
$476B
| $56.5M | 0.09% |
1,483,079
-2,051,316
| -58% | -$72.9M |
|
|
HTZ
284
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $56.4M | 0.09% |
2,904,479
-344,762
| -11% | -$5.43M |
|
|
CTXS
285
DELISTED
Citrix Systems Inc
CTXS
| $56.4M | 0.09% |
734,035
-467,279
| -39% | -$36.3M |
|
|
286
PUT
IBM
IBM
$222B
| $56.1M | 0.09% |
404,279
+20,188
| +5% | +$2.81M |
|
|
EGN
287
DELISTED
Energen
EGN
| $55.8M | 0.09% |
1,019,832
-231,560
| -19% | -$11.8M |
|
|
288
CALL
IBM
IBM
$222B
| $55.7M | 0.09% |
401,873
+139,745
| +53% | +$19.5M |
|
|
AAN.A
289
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $55.7M | 0.09% |
1,277,485
+188,615
| +17% | +$8.23M |
|
|
BKHU
290
DELISTED
Black Hills Corporation
BKHU
| $55.7M | 0.09% |
741,977
| – | – |
|
291
CALL
Caterpillar
CAT
$381B
| $55.7M | 0.09% |
446,400
+28,300
| +7% | +$3.26M |
|
|
PTLA
292
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $55.7M | 0.09% |
1,030,022
-144,908
| -12% | -$8.51M |
|
293
PUT
Halliburton
HAL
$29.4B
| $55.6M | 0.09% |
1,208,200
+108,300
| +10% | +$4.54M |
|
294
Universal Health Services
UHS
$10.4B
| $55.4M | 0.09% |
499,373
-351,292
| -41% | -$39.5M |
|
295
Pitney Bowes
PBI
$2.26B
| $55.3M | 0.08% |
3,945,544
-295,542
| -7% | -$4.06M |
|
296
Wynn Resorts
WYNN
$10.3B
| $55.2M | 0.08% |
370,647
+300,487
| +428% | +$41M |
|
297
Itaú Unibanco
ITUB
$82.4B
| $55.1M | 0.08% |
8,289,684
+5,569,745
| +205% | +$34M |
|
298
Nucor
NUE
$55.3B
| $54.5M | 0.08% |
972,312
-173,015
| -15% | -$9.78M |
|
|
HDS
299
DELISTED
HD Supply Holdings, Inc.
HDS
| $54.2M | 0.08% |
1,502,389
-675,813
| -31% | -$21.7M |
|
300
M&T Bank
MTB
$34.7B
| $53.7M | 0.08% |
333,685
+112,497
| +51% | +$17.7M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.